Antibiotic Discontinuation in Neutropenic Patients With Acute Myeloid Leukemia
Discontinuing antibacterial therapy in neutropenic patients with acute myeloid leukemia did not lead to excessive mortality or severe infections.
Home
New Tool for Reconstituting Factor VIII for Hemophilia A Prophylaxis
Simplifying factor VIII reconstitution may increase treatment adherence and satisfaction in patients with hemophilia A.
Current Standing and Future Directions of CAR T Therapy for Chronic Lymphocytic Leukemia
CAR T therapy has emerged in recent years as a feasible treatment for patients with chronic lymphocytic leukemia, but there are still many unanswered questions.
Consensus Panel on Maintenance Therapies Following Autologous Hematopoietic Cell Transplantation in Lymphoma
An expert panel reviewed current literature surrounding lymphoma treatment to identify and address any gaps in knowledge.
Optimal Platelet Transfusion Threshold Unknown in Patients Undergoing Lumbar or Epidural Procedures
Unnecessarily high platelet count thresholds may expose patients undergoing lumbar or epidural procedures to excessive transfusion-related risks.
FDA Places Clinical Hold on Venetoclax Trials for Multiple Myeloma
This action does not impact currently approved indications for venetoclax.
Overcoming Challenges in Mechanical Circulatory Support: A Guide for Hematologists
Mechanical circulatory support (MCS) devices can lead to hemostatic events, making it crucial to include a hematologist on a patient’s MCS management team.
Quantifying Adherence to Mucormycosis Treatment Guidelines in Patients With Hematologic Malignancies
Adhering to mucormycosis treatment guidelines may be difficult for physicians because of the complexity of the disease.
Novel Risk Factors for Veno-Occlusive Disease Following Hematopoietic Stem Cell Transplantation
Busulfan usage, high ferritin levels prior to HSCT, and treatment with some antibody-drug conjugates were deemed to be risk facts for VOD/SOS.
Managing Neonatal Thrombocytopenia of Alloimmune Origin
A French working group developed a treatment algorithm for diagnosis and treatment of neonatal thrombocytopenia of suspected or confirmed alloimmune origin.
Want to read more?
Please login or register first to view this content.
Next post in Thrombotic Disorders
